Arthur T. Sands

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Daniel Burbach, as Attorney-in-Fact for Arthur T. Sands
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Arthur T. Sands

Form 4 holding President, CEO, Director

Nurix Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
562,500
Estimated value
Report date
10 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Arthur T. Sands

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .